PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United …
Over the last 12 months, insiders at PROCEPT BioRobotics Corporation have bought $0 and sold $84.91M worth of PROCEPT BioRobotics Corporation stock.
On average, over the past 5 years, insiders at PROCEPT BioRobotics Corporation have bought $39.47M and sold $31.75M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 940 shares for transaction amount of $22,961 was made by Wood Morgan Colby () on 2022‑03‑11.
2024-11-13 | Sale | President, CEO | 26,420 0.0491% | $94.08 | $2.49M | -1.55% | ||
2024-11-07 | Sale | director | 34,000 0.0621% | $95.39 | $3.24M | -2.19% | ||
2024-11-06 | Sale | director | 33,000 0.0604% | $97.04 | $3.2M | -2.73% | ||
2024-11-05 | Sale | director | 33,000 0.0605% | $96.60 | $3.19M | -1.02% | ||
2024-10-30 | Sale | President, CEO | 288,461 0.5433% | $91.00 | $26.25M | +2.71% | ||
2024-10-15 | Sale | EVP, CFO | 25,000 0.044% | $72.47 | $1.81M | +28.57% | ||
2024-09-16 | Sale | EVP, CFO | 25,000 0.0484% | $82.51 | $2.06M | -2.28% | ||
2024-09-12 | Sale | director | 44,867 0.0861% | $80.11 | $3.59M | -0.20% | ||
2024-09-11 | Sale | director | 38,698 0.0751% | $77.54 | $3M | +3.68% | ||
2024-09-10 | Sale | director | 36,500 0.0696% | $76.18 | $2.78M | +4.38% | ||
2024-09-05 | Sale | director | 13,305 0.0256% | $76.37 | $1.02M | +4.94% | ||
2024-09-04 | Sale | director | 36,212 0.0692% | $75.42 | $2.73M | +5.19% | ||
2024-09-04 | Sale | director | 53,632 0.1025% | $75.42 | $4.04M | +5.19% | ||
2024-09-03 | Sale | director | 35,120 0.0686% | $76.11 | $2.67M | +6.33% | ||
2024-09-03 | Sale | director | 35,220 0.0688% | $76.12 | $2.68M | +6.33% | ||
2024-06-17 | Sale | EVP, CLO, CORP. SEC. | 10,000 0.018% | $62.18 | $621,764 | +21.59% | ||
2024-06-10 | Sale | EVP, Chief Comm. Officer | 26,046 0.0503% | $68.24 | $1.78M | +7.92% | ||
2024-05-03 | Sale | EVP, CLO, CORP. SEC. | 30,432 0.058% | $62.97 | $1.92M | +7.48% | ||
2024-05-01 | Sale | director | 20,000 0.0385% | $60.00 | $1.2M | +13.98% | ||
2024-03-18 | Sale | President, CEO | 5,391 0.0106% | $48.83 | $263,243 | +37.22% |
MOLL FREDERIC H | director | 808233 1.4859% | $94.44 | 1 | 1 | <0.0001% |
Desai Antal Rohit | director | 164363 0.3022% | $94.44 | 1 | 11 | <0.0001% |
Krummel Thomas M | director | 45631 0.0839% | $94.44 | 1 | 3 | <0.0001% |
CPMG Inc | 10 percent owner | 11222662 20.6319% | $94.44 | 1 | 0 | <0.0001% |
VIKING GLOBAL INVESTORS LP | 10 percent owner | 400000 0.7354% | $94.44 | 1 | 0 | <0.0001% |
Fidelity Investments | $371.83M | 14.63 | 7.52M | +2.2% | +$8.01M | 0.03 | |
Cpmg Inc | $263.35M | 10.36 | 5.33M | 0% | +$0 | 95.58 | |
The Vanguard Group | $209.87M | 8.26 | 4.25M | +1.49% | +$3.07M | <0.01 | |
BlackRock | $162.72M | 6.4 | 3.29M | -1.94% | -$3.22M | <0.01 | |
T Rowe Price Investment Management Inc | $145.29M | 5.72 | 2.94M | -20.44% | -$37.32M | 0.09 |